Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events

Author： Yinon Yoav   Pauzner Rachel   Dulitzky Mordechai   Elizur Shai E   Dor Jehoshua   Shulman Adrian  

Publisher： Reproductive Healthcare Ltd

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.12, Iss.3, 2006-03, pp. : 354-358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eptacog-α: Thrombo-embolic events in paediatric patients: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1252, 2009-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Prognostic Value of INR Fluctuations during Anticoagulant Therapy in Patients with Atrial Fibrillation and a High Thromboembolic Risk

By  

Heart Drug, Vol. 4, Iss. 2, 2004-05 ,pp. : 80-86

Karger

Access to resources Recommend Favorite

Increased risk of thromboembolic events with Avastin

By  

Reactions Weekly, Vol. 1, Iss. 1015, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The risk of arterial thromboembolic events with chemotherapy appears to be increased with the addition of bevacizumab [Avastin]

By  

Inpharma, Vol. 1, Iss. 1492, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Thromboembolic events a risk in off-label use of rFVIIa

By  

Reactions Weekly, Vol. 1, Iss. 1327, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite